Suffern, NY, United States of America

Nitin K Swarnakar

This inventor holds 1 USPTO granted patent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nitin K Swarnakar. Retrieved from https://idiyas.com/inventor/nitin-k-swarnakar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nitin K. Swarnakar and Proliposomal Testosterone Undecanoate Formulations

Introduction

Nitin K. Swarnakar is an inventor based in Suffern, New York. His patent work includes a pharmaceutical formulation involving testosterone undecanoate and phospholipids.

Latest Patents

Swarnakar is associated with 1 patent, titled “Proliposomal Testosterone Undecanoate Formulations.” The invention describes proliposomal powder dispersions combining testosterone undecanoate (TU) with selected phospholipids. Examples include TU and dipalmitoylphosphatidylcholine (DPPC) at an approximate 1:2 weight-to-weight ratio, TU and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) at approximately 1:3, and TU and 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC) at approximately 1:3.

Career Highlights

The patent highlights Swarnakar’s contribution to pharmaceutical formulation innovation, specifically the development of proliposomal powder dispersions containing testosterone undecanoate and phospholipids. The provided information identifies this patent as his recorded patent contribution.

Collaborations

Swarnakar’s listed coworkers include Veeran Gowda Kadajji and Guru V. Betageri, reflecting collaboration in the development or patenting of the formulation.

Conclusion

Nitin K. Swarnakar’s patent on proliposomal testosterone undecanoate formulations documents an innovation focused on combining TU with selected phospholipids at specified ratios.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…